AGIO

Agios (AGIO) Files MAA in EU for Rare Genetic Disease Drug

Agios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency

Agios (AGIO) Files NDA to FDA for Rare Disease Drug Mitapivat

Agios Launches myAgios® Patient Support Services for Pyruvate Kinase Deficiency

Agios Pharma Files US Application For Mitapivat In PK Deficiency

Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency